Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis

Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis

Background. For patients with colorectal cancer (CRC) peritoneal metastases (PM) who are eligible for cytoreductive surgery (CRS), the indication and timing of systemic chemotherapy (SC) are still under debate. This study aims to analyze the role of pre, post or perioperative SC on the survival and...

Full description

Bibliographic Details
Main Authors:	Marco Tonello, Carola Cenzi, Elisa Pizzolato, Riccardo Fiscon, Paola Del Bianco, Pierluigi Pilati, Antonio Sommariva
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Cancers
Subjects:	peritoneal metastases (PM) cytoreductive surgery (CRS) HIPEC colorectal cancer systemic chemotherapy (SC)
Online Access:	https://www.mdpi.com/2072-6694/16/6/1182

Similar Items

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
by: Enrico Maria Pasqual, et al.
Published: (2023-01-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal Metastases
by: Vincent C. J. van de Vlasakker, et al.
Published: (2023-01-01)

Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review
by: Antonio Sommariva, et al.
Published: (2022-12-01)

Hyperthermic intraperitoneal chemotherapy following up-front cytoreductive surgery versus cytoreductive surgery alone for isolated synchronous colorectal peritoneal metastases: A retrospective, observational study
by: Xiusen Qin, et al.
Published: (2022-10-01)

Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery
by: Mina Sarofim, et al.
Published: (2024-04-01)

Synchronous liver and peritoneal metastases from colorectal cancer: Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option?
by: Sara Di Carlo, et al.
Published: (2022-12-01)

The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis
by: Francesco Santullo, et al.
Published: (2022-05-01)

Novel Perspectives in Pseudomyxoma Peritonei Treatment
by: Antonio Sommariva, et al.
Published: (2021-11-01)

Gastric Cancer with Peritoneal Metastases: Current Status and Prospects for Treatment
by: Israel Manzanedo, et al.
Published: (2023-03-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes
by: Jerzy Mielko, et al.
Published: (2020-08-01)

Editorial: Management of peritoneal surface malignancies. (cytoreductive surgery, HIPEC, PIPAC, and beyond)
by: Amine Souadka, et al.
Published: (2024-03-01)

Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Peritoneal Disease Management
by: Antonio Sommariva, et al.
Published: (2022-12-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
by: Kevin M. Turner, et al.
Published: (2022-06-01)

Diaphragmatic peritoneal metastases mimicking liver metastases
by: Noiret Barbara, et al.
Published: (2021-08-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases – The Hong Kong experience and literature review
by: Felix Che-lok Chow, et al.
Published: (2021-01-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies
by: Megan M. Harper, et al.
Published: (2022-05-01)

Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)
by: Israel Manzanedo, et al.
Published: (2023-05-01)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review
by: Chen Vicky, et al.
Published: (2022-11-01)

The prognostic impact of lead times in colorectal cancer patients undergoing cytoreductive surgery and HIPEC
by: Ylva Jansson, et al.
Published: (2022-09-01)

Conversion Surgery with HIPEC for Peritoneal Oligometastatic Gastric Cancer
by: Jerzy Mielko, et al.
Published: (2019-11-01)

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)
by: Pedro Villarejo Campos, et al.
Published: (2024-01-01)

Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases
by: Beatrice J. Sun, et al.
Published: (2022-01-01)

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies
by: Louis Choon Kit Wong, et al.
Published: (2022-12-01)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
by: Miklos Acs, et al.
Published: (2022-07-01)

Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
by: Waheed Yousry Gareer, et al.
Published: (2022-06-01)

Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors
by: Philipp Horvath, et al.
Published: (2021-05-01)

Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis
by: Alba Fernández-Candela, et al.
Published: (2021-06-01)

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases
by: Fernando Pereira, et al.
Published: (2022-05-01)

Therapeutic Strategies and Oncological Outcome of Peritoneal Metastases from Lung Cancer: A Systematic Review and Pooled Analysis
by: Leandro Siragusa, et al.
Published: (2023-03-01)

Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups
by: Manuel Gomes David, et al.
Published: (2022-01-01)

Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
by: Mina Sarofim, et al.
Published: (2024-04-01)

Enhanced recovery after surgery in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: national survey of peri-operative practice by Indian society of peritoneal surface malignancies
by: Somashekhar Sampige Prasanna, et al.
Published: (2023-05-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience
by: Fabio Carboni, et al.
Published: (2021-01-01)

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond
by: Christopher W. Mangieri, et al.
Published: (2022-11-01)

The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study
by: Checca Bakkers, et al.
Published: (2023-01-01)

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients
by: Anna Weiss, et al.
Published: (2018-04-01)

Peritoneal metastases from mucinous endocervical adenocarcinoma
by: Paul H. Sugarbaker, et al.
Published: (2014-12-01)

Laparoscopy for risk-reducing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (case series and review of literature)
by: Vedrana Biošić, et al.
Published: (2023-01-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)